SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years

Author(s):

Louise C. Rowntree, Jennifer Audsley, Lilith F. Allen, Hayley A. McQuilten, Ruth R. Hagen, Priyanka Chaurasia, Jan Petersen, Dene R. Littler, Hyon Xhi Tan, Lydia Murdiyarso, Jennifer R. Habel, Isabelle J.H. Foo, Wuji Zhang, Elizabeth R.V. ten Berge, Hanujah Ganesh, Prathanporn Kaewpreedee, Kelly W.K. Lee, Samuel M.S. Cheng, Janette S.Y. Kwok, Dhilshan Jayasinghe, Stephanie Gras, Jennifer A. Juno, Adam K. Wheatley, Stephen J. Kent, Jamie Rossjohn, Allen C. Cheng, Tom C. Kotsimbos, Jason A. Trubiano, Natasha E. Holmes, Ken Ka Pang Chan, David S.C. Hui, Malik Peiris, Leo L.M. Poon, Sharon R. Lewin, Peter C. Doherty, Irani Thevarajan, Sophie A. Valkenburg, Katherine Kedzierska, Thi H.O. Nguyen

Details:

Proceedings of the National Academy of Sciences of the United States of America, Volume 121, Issue 39, 2024-09-24, Article number e2411428121

Article Link: Click here

Affiliations:

• University of Melbourne
• Monash University
• La Trobe University
• Royal Melbourne Hospital
• Prince of Wales Hospital Hong Kong
• Queen Mary Hospital Hong Kong
• The Alfred
• Peter Maccallum Cancer Centre
• The University of Hong Kong Li Ka Shing Faculty of Medicine
• Austin Health
• Chinese University of Hong Kong, Faculty of Medicine
• Cardiff University School of Medicine
• The Peter Doherty Institute for Infection and Immunity
• HKU-Pasteur Research Pole
• Centre for Immunology and Infection